The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback